View Post

Ultrasound-guided microbubbles boost immunotherapy efficacy

In In The News by Barbara Jacoby

From: MD Anderson developed a platform to improve both antitumor immune responses and responses to checkpoint inhibitors Researchers at The University of Texas MD Anderson Cancer Center have developed an ultrasound-guided cancer immunotherapy platform that generates systemic antitumor immunity and improves the therapeutic efficacy of immune checkpoint blockade. The findings from the preclinical study were published today in Nature …

View Post

Therapeutics Discovery division advances novel small-molecule to clinic

In Clinical Studies News by Barbara Jacoby

By: Clayton R. Boldt, Ph.D. From: The Therapeutics Discovery division at MD Anderson Cancer Center has advanced a new small-molecule inhibitor of cancer metabolism to Phase I clinical trials. This new drug candidate marks the fourth novel therapeutic brought from concept to clinical trial by Therapeutics Discovery, a drug-discovery engine built within the walls of MD Anderson to eliminate …